MONICA MILLER: Open Payments
NPI 1588326037 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 117 payments from 24 companies in 2025. Trend: 2023 $2,870 · 2024 $1,286 · 2025 $2,300
Food & beverage: $2,300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $447 |
| Axsome Therapeutics, Inc. | 13 | $278 |
| Amgen Inc. | 12 | $271 |
| Lundbeck LLC | 7 | $150 |
| PFIZER INC. | 5 | $129 |
| Indivior Inc. | 5 | $123 |
| Novo Nordisk Inc | 5 | $105 |
| Lilly USA, LLC | 5 | $93 |
| Orexo US, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
Products named: Sunosi, VRAYLAR, REXULTI, OTEZLA, NURTEC ODT, SUBLOCADE, QULIPTA, LINZESS.
Industry payments across MD — which companies pay providers there.
